Sep 30, 2020

Workhorse Q3 2020 Earnings Report

Workhorse reported a net loss of $84.1 million due to increased interest expense but sales increased to $565,000.

Key Takeaways

Workhorse Group Inc. reported third-quarter results with increased sales of $565,000 compared to $4,000 in the same period last year. The company's net loss was $84.1 million, primarily due to a significant increase in interest expense. Despite production delays, Workhorse aims to produce approximately 1,800 units in 2021.

Set a production volume target of 1,800 vehicles for 2021.

Received an order for 500 C-1000 trucks from Pritchard Auto Company, financed by Hitachi Capital America.

Improved cash position to over $260 million through various financings.

Strategic partner Lordstown Motor Corporation completed its merger and Workhorse maintained its 10% ownership stake.

Total Revenue
$565K
Previous year: $4.26K
+13162.3%
EPS
-$15.6
Previous year: -$3.4
+358.8%
Gross Profit
-$2.25M
Cash and Equivalents
$80.2M
Free Cash Flow
-$20.6M
Total Assets
$120M

Workhorse

Workhorse

Forward Guidance

Workhorse anticipates producing approximately 1,800 units in 2021, but faces potential challenges from battery supply and COVID-19 impacts.

Positive Outlook

  • Supplemental battery volume additions expected in Q1 2021.
  • Strategic partnership with Hitachi to optimize manufacturing and supply chain.
  • Dealer network development with Hitachi Capital America to support sales and financing.
  • Positive dealer survey results regarding the EV delivery truck market and Workhorse's prospects.
  • Expects to produce approximately 1,800 units in 2021 when COVID conditions improve

Challenges Ahead

  • Inability of primary battery supplier to meet volumes due to capacity issues and COVID-related slowdowns.
  • COVID-19 impact with a significant portion of production staff out with the virus or quarantined.
  • Modified assembly process and limited third-party production support due to COVID-19.
  • Production delays in Q4 due to battery supply and COVID-19 issues.
  • Uncertainty about the full impact of COVID-19 in 2021.